130683569	130683569	CD	B-NP	O
|	|	NN	I-NP	O
PCMC	PCMC	NN	I-NP	O
|	|	NN	I-NP	O
35220680	35220680	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8498595	8498595	CD	B-NP	O
|	|	CC	I-NP	O
8/27/2006	8/27/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/27/2006	8/27/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
JOSILOWSKY	JOSILOWSKY	NNP	B-NP	O
,	,	,	O	O
ODELL	ODELL	NNP	B-NP	O
MD	MD	NNP	I-NP	O
PRIMARY	PRIMARY	NNP	I-NP	O
CARE	CARE	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Freddie	Freddie	NNP	I-NP	O
Fluegge	Fluegge	NNP	I-NP	O
,	,	,	O	O
216-754-4187	216-754-4187	CD	B-NP	O
CHIEF	CHIEF	NN	I-NP	O
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Sepsis	Sepsis	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Wiest	Wiest	NNP	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
83-year-old	83-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
CAD	CAD	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
EF	EF	NN	I-NP	I-protein
55	55	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
sepsis	sepsis	NN	B-NP	O
from	from	IN	B-PP	O
right	right	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
developed	develop	VBD	B-VP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
developed	develop	VBD	B-VP	O
worsening	worsen	VBG	I-VP	O
erythema	erythema	NN	B-NP	O
,	,	,	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	I-NP	O
tenderness	tenderness	NN	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
chills	chill	NNS	B-NP	O
and	and	CC	I-NP	O
sweats	sweat	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
8/7/06	8/7/06	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
80s	80	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
and	and	CC	O	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
aztreonam	aztreonam	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
clindamycin	clindamycin	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
remained	remain	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
dopamine	dopamine	NN	B-NP	O
,	,	,	O	O
Levophed	Levophed	JJ	B-NP	O
and	and	CC	I-NP	O
vasopressin	vasopressin	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Decadron	Decadron	NNP	B-NP	O
.	.	.	O	O

Surgery	Surgery	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
biopsy	biopsy	NN	B-NP	O
as	as	IN	B-SBAR	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
necrotizing	necrotize	VBG	B-VP	O
fascitis	fascitis	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
CT	CT	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
.	.	.	O	O

Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
grew	grow	VBD	B-VP	O
group	group	NN	B-NP	O
A	A	NN	I-NP	O
streptococcus	streptococcus	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-cell_line
wound	wound	JJ	I-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
grew	grow	VBD	B-VP	O
group	group	NN	B-NP	O
A	A	NN	I-NP	O
strep	strep	NN	I-NP	O
and	and	CC	O	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
dx	dx	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
klebseilla	klebseilla	NN	I-NP	O
UTI	UTI	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
improved	improve	VBD	B-VP	O
and	and	CC	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
oliguric	oliguric	JJ	B-ADJP	O
,	,	,	O	O
presumably	presumably	RB	B-NP	O
due	due	JJ	I-NP	O
ATN	ATN	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
hypotension	hypotension	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
drop	drop	VB	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
metabolic	metabolic	JJ	I-NP	O
acidosis	acidosis	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
bicarbonate	bicarbonate	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lactic	lactic	JJ	I-NP	O
acid	acid	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
was	be	VBD	B-VP	O
4.4	4.4	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ABG	ABG	NN	I-NP	O
was	be	VBD	B-VP	O
:	:	:	O	O
7	7	CD	B-NP	O
.	.	.	O	O

9/23/98	9/23/98	CD	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
perspective	perspective	NN	I-NP	O
,	,	,	O	O
ARF	ARF	NN	B-NP	B-protein
was	be	VBD	B-VP	O
less	less	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
post-streptococcal	post-streptococcal	JJ	B-NP	O
glomerulonephritis	glomerulonephritis	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
timing	timing	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
strep	strep	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
hypertension	hypertension	NN	I-NP	O
or	or	CC	I-NP	O
WBC	WBC	NN	I-NP	B-cell_line
casts	cast	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
UA	UA	NNP	I-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
hematuria	hematuria	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
low	low	JJ	B-NP	O
complement	complement	NN	I-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
so	so	IN	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
HUS	HUS	NN	B-NP	O
after	after	IN	B-PP	O
group	group	NN	B-NP	O
B	B	NN	I-NP	O
strep	strep	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
schistocytes	schistocyte	NNS	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
smear	smear	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
was	be	VBD	B-VP	O
aneuric	aneuric	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
and	and	CC	O	O
she	she	PRP	B-NP	O
started	start	VBD	B-VP	O
renal	renal	JJ	B-NP	O
replacement	replacement	NN	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
recovered	recover	VBD	B-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
800	800	CD	B-NP	O
mL	mL	NN	I-NP	O
daily	daily	RB	B-ADVP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
4/30/06	4/30/06	CD	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
started	start	VBD	B-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
started	start	VBD	B-VP	O
intermittent	intermittent	JJ	B-NP	O
dialysis	dialysis	NN	I-NP	O
via	via	IN	B-PP	O
a	a	DT	B-NP	O
tunneled	tunnel	VBN	I-NP	O
LIJ	LIJ	NN	I-NP	O
catheter	catheter	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
renal	renal	JJ	I-NP	O
team	team	NN	I-NP	O
followed	follow	VBD	B-VP	O
her	her	PRP	B-NP	O
closely	closely	RB	B-ADVP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
meds	med	NNS	I-NP	O
were	be	VBD	B-VP	O
renally	renally	RB	I-VP	O
dosed	dose	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
was	be	VBD	B-VP	O
dosed	dose	VBN	I-VP	O
by	by	IN	B-PP	O
level	level	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
has	have	VBZ	B-VP	O
normalized	normalize	VBN	I-VP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
titrated	titrate	VBN	B-NP	O
upwards	upward	NNS	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
perspective	perspective	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
pt	pt	NN	I-NP	O
's	's	POS	B-NP	O
troponin	troponin	NN	I-NP	O
hit	hit	VBD	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
of	of	IN	B-PP	O
0.87	0.87	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
septic	septic	JJ	B-NP	O
shock	shock	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
MMMC	MMMC	NN	B-NP	O
cardiology	cardiology	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
demand	demand	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
actually	actually	RB	I-VP	O
been	be	VBN	I-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
daily	daily	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
LDL	LDL	NN	I-NP	B-protein
was	be	VBD	B-VP	O
63	63	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
statin	statin	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
actually	actually	RB	I-VP	O
need	need	VB	I-VP	O
her	her	PRP$	B-NP	O
fasting	fast	VBG	I-NP	O
lipids	lipid	NNS	I-NP	O
checked	check	VBD	B-VP	O
once	once	RB	B-ADVP	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
illness	illness	NN	I-NP	O
has	have	VBZ	B-VP	O
passed	pass	VBN	I-VP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
LDL	LDL	NN	I-NP	O
goal	goal	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
70	70	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
AFIB	AFIB	NN	B-NP	B-protein
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	O
goal	goal	NN	I-NP	O
is	be	VBZ	B-VP	O
2-3	2-3	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
drifting	drift	VBG	I-VP	O
down	down	RP	B-PRT	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
off	off	RB	B-ADVP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
several	several	JJ	B-NP	O
lines	line	NNS	I-NP	O
that	that	WDT	B-NP	O
needed	need	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
pulled	pull	VBN	I-VP	O
,	,	,	O	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
subclavian	subclavian	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
catheter	catheter	NN	I-NP	O
will	will	MD	B-VP	O
either	either	RB	I-VP	O
be	be	VB	I-VP	O
removed	remove	VBN	I-VP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
improved	improve	VBN	I-VP	O
urine	urine	NN	B-NP	O
output	output	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
permanent	permanent	JJ	I-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
access	access	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
prophylactic	prophylactic	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
hits	hit	VBZ	B-VP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
hematologic	hematologic	JJ	I-NP	O
perspective	perspective	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
had	have	VBD	B-VP	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
DIC	DIC	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
quick	quick	JJ	I-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
.	.	.	O	O

Fibrinogen	Fibrinogen	NN	B-NP	B-protein
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
has	have	VBZ	B-VP	O
since	since	IN	I-VP	O
stabilized	stabilize	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
persistent	persistent	JJ	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
her	her	PRP$	B-NP	O
platelet	platelet	NN	I-NP	O
count	count	NN	I-NP	O
is	be	VBZ	B-VP	O
recovering	recover	VBG	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
platelet	platelet	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
precipitant	precipitant	JJ	I-NP	O
other	other	JJ	I-NP	O
than	than	IN	B-PP	O
sepsis	sepsis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
normocytic	normocytic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
hematocrit	hematocrit	NN	B-NP	O
since	since	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
hemolysis	hemolysis	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
rising	rise	VBG	I-NP	O
bilirubin	bilirubin	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
haptoglobin	haptoglobin	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
immature	immature	JJ	I-NP	B-cell_type
erythrocytes	erythrocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
schistocytes	schistocyte	NNS	I-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
on	on	IN	B-PP	O
manual	manual	JJ	B-NP	O
diff	diff	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
require	require	VB	I-VP	O
two	two	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
and	and	CC	I-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
did	do	VBD	B-VP	O
drop	drop	NN	B-NP	O
on	on	IN	B-PP	O
2/27/06	2/27/06	CD	B-NP	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
steroids	steroid	NNS	I-NP	O
were	be	VBD	B-VP	O
being	be	VBG	I-VP	O
tapered	taper	VBN	I-VP	O
off	off	RP	B-PRT	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
direct	direct	JJ	I-NP	O
Coombs	Coombs	NNP	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Haptoglobin	Haptoglobin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Medications	Medication	NNS	B-NP	O
causing	cause	VBG	B-VP	O
her	her	PRP$	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
like	like	IN	B-PP	O
Seroquel	Seroquel	NN	B-NP	O
and	and	CC	I-NP	O
heparin	heparin	NN	I-NP	O
were	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
oxygenating	oxygenate	VBG	I-VP	O
and	and	CC	I-VP	O
ventilating	ventilate	VBG	I-VP	O
well	well	RB	B-VP	O
and	and	CC	I-VP	O
not	not	RB	I-VP	O
requiring	require	VBG	I-VP	O
any	any	DT	B-NP	O
supplemental	supplemental	JJ	I-NP	O
O2	O2	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
started	start	VBD	B-VP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
on	on	IN	B-PP	O
11/9/06	11/9/06	CD	B-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
marked	marked	JJ	I-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
steroids	steroid	NNS	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
hypotension	hypotension	NN	I-NP	O
contributing	contribute	VBG	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
actually	actually	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
IV	IV	CD	I-NP	O
insulin	insulin	NN	I-NP	O
protocol	protocol	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
plus	plus	CC	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
previously	previously	RB	B-ADVP	O
Lantus	Lantus	NNP	B-NP	O
25	25	CD	I-NP	O
units	unit	NNS	I-NP	O
SC	SC	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
TSH	TSH	NN	I-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
levothyroxine	levothyroxine	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
fourth	fourth	JJ	I-NP	O
finger	finger	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
PIP	PIP	NN	I-NP	O
joint	joint	NN	I-NP	O
was	be	VBD	B-VP	O
tapped	tap	VBN	I-VP	O
on	on	IN	B-PP	O
2/27/06	2/27/06	CD	B-NP	O
by	by	IN	B-PP	O
rheumatology	rheumatology	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
appearance	appearance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fluid	fluid	NN	I-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
gout	gout	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
right	right	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
infectious	infectious	JJ	B-ADJP	O
per	per	IN	B-PP	O
radiology	radiology	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Decadron	Decadron	NNP	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
and	and	CC	O	O
only	only	RB	B-VP	O
has	have	VBZ	I-VP	O
mild	mild	JJ	B-NP	O
,	,	,	I-NP	O
residual	residual	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
GI	GI	NN	I-NP	O
perspective	perspective	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
LFTs	LFT	NNS	I-NP	O
rose	rise	VBD	B-VP	O
on	on	IN	B-PP	O
8/27/06	8/27/06	CD	B-NP	O
with	with	IN	B-PP	O
peak	peak	JJ	B-NP	O
ALT	ALT	NN	I-NP	O
of	of	IN	B-PP	O
122	122	CD	B-NP	O
,	,	,	O	O
T	T	NN	B-NP	O
bili	bili	NNS	I-NP	O
of	of	IN	B-PP	O
8.7	8.7	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
alkaline	alkaline	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
of	of	IN	B-PP	O
196	196	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
rising	rise	VBG	I-NP	O
INR	INR	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-VP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
-RRB-	-RRB-	HYPH	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
hepatic	hepatic	JJ	B-NP	O
injury	injury	NN	I-NP	O
and	and	CC	O	O
hepatocellular	hepatocellular	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

GI	GI	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
etiology	etiology	NN	I-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
differential	differential	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
was	be	VBD	B-VP	O
drug	drug	NN	B-NP	O
related	related	JJ	I-NP	O
liver	liver	NN	I-NP	O
injury	injury	NN	I-NP	O
versus	versus	IN	B-PP	O
infection	infection	NN	B-NP	O
or	or	CC	O	O
shock	shock	NN	B-NP	O
liver	liver	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
less	less	RBR	B-NP	O
likely	likely	JJ	I-NP	O
,	,	,	I-NP	O
fatty	fatty	JJ	I-NP	O
liver	liver	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
serologies	serology	NNS	I-NP	O
are	be	VBP	B-VP	O
negative	negative	JJ	B-ADJP	O
and	and	CC	O	O
Tylenol	Tylenol	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
held	hold	VBN	I-VP	O
since	since	IN	B-PP	O
8/27/06	8/27/06	CD	B-NP	O
.	.	.	O	O

Flagyl	Flagyl	NN	B-NP	O
and	and	CC	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
11/9/06	11/9/06	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
.	.	.	O	O

AMA	AMA	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

ASMA	ASMA	NN	B-NP	O
was	be	VBD	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
neurologic	neurologic	JJ	I-NP	O
point	point	NN	I-NP	O
of	of	IN	B-PP	O
view	view	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
required	require	VBD	B-VP	O
Dilaudid	Dilaudid	JJ	B-NP	O
PCA	PCA	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
fentanyl	fentanyl	NN	I-NP	O
patch	patch	NN	I-NP	O
with	with	IN	B-PP	O
Dilaudid	Dilaudid	JJ	B-NP	O
boluses	bolus	NNS	I-NP	O
.	.	.	O	O

Seroquel	Seroquel	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
for	for	IN	B-PP	O
sedation	sedation	NN	B-NP	O
and	and	CC	O	O
that	that	DT	B-NP	O
was	be	VBD	B-VP	O
actually	actually	RB	I-VP	O
stopped	stop	VBN	I-VP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
dermatologic	dermatologic	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
left	leave	VBN	I-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
venostasis	venostasis	NN	I-NP	O
ulcers	ulcer	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
right	right	RB	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
arterial	arterial	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
wound	wound	NN	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

Vascular	Vascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
requested	request	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
have	have	VBP	B-VP	O
ABIs	ABI	NNS	B-NP	O
and	and	CC	O	O
assessment	assessment	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
vascular	vascular	JJ	I-NP	O
flow	flow	NN	I-NP	O
once	once	IN	B-SBAR	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
illness	illness	NN	I-NP	O
has	have	VBZ	B-VP	O
passed	pass	VBN	I-VP	O
.	.	.	O	O

For	For	IN	B-PP	O
nutrition	nutrition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
started	start	VBD	B-VP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
through	through	IN	B-PP	O
an	an	DT	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
prolonged	prolonged	JJ	I-NP	O
sedation	sedation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
her	her	PRP$	B-NP	O
nutritional	nutritional	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
speech	speech	NN	I-NP	O
and	and	CC	I-NP	O
swallow	swallow	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
on	on	IN	B-PP	O
10/27/07	10/27/07	CD	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
approved	approve	VBN	I-VP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
access	access	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
subclavian	subclavian	JJ	I-NP	O
left	left	JJ	I-NP	O
IJ	IJ	NN	I-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
catheter	catheter	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	B-cell_line
radial	radial	JJ	I-NP	I-cell_line
artery	artery	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
1/3/06	1/3/06	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
subclavian	subclavian	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
removed	remove	VBN	I-VP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
1.5	1.5	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
catheter	catheter	NN	I-NP	O
will	will	MD	B-VP	O
either	either	RB	I-VP	O
be	be	VB	I-VP	O
removed	remove	VBN	I-VP	O
or	or	CC	I-VP	O
replaced	replace	VBN	I-VP	O
with	with	IN	B-PP	O
more	more	RBR	B-NP	O
permanent	permanent	JJ	I-NP	O
access	access	NN	I-NP	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
pneumo	pneumo	NN	B-NP	O
boots	boot	NNS	I-NP	O
on	on	IN	B-PP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
cellulitis	cellulitis	NN	B-NP	O
and	and	CC	I-NP	O
heparin	heparin	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
with	with	IN	B-PP	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
10/27/07	10/27/07	CD	B-NP	O
or	or	CC	O	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
1.5	1.5	CD	B-NP	O
rather	rather	RB	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Diabetes	Diabetes	NN	B-NP	B-protein
mellitus	mellitus	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
II	II	CD	I-NP	I-protein
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
status	status	NN	I-NP	I-protein
post	post	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	O
1998	1998	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
saphenous	saphenous	JJ	I-NP	O
vein	vein	NN	I-NP	O
was	be	VBD	B-VP	O
harvested	harvest	VBN	I-VP	O
for	for	IN	B-PP	O
surgery	surgery	NN	B-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
baseline	baseline	NN	B-NP	O
swelling	swelling	NN	I-NP	O
and	and	CC	I-NP	O
edema	edema	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
2004	2004	CD	I-NP	O
,	,	,	O	O
dry	dry	JJ	B-NP	O
weight	weight	NN	I-NP	O
is	be	VBZ	B-VP	O
150	150	CD	B-NP	O
pounds	pound	NNS	I-NP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

Sick	Sick	NN	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
permanent	permanent	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
placement	placement	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2006	2006	CD	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
hemothorax	hemothorax	NN	B-NP	O
requiring	require	VBG	B-VP	O
thoracoscopy	thoracoscopy	NN	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
total	total	JJ	B-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
right	right	JJ	B-NP	O
total	total	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
in	in	IN	B-PP	O
1990	1990	CD	B-NP	O
,	,	,	O	O
hypothyroid	hypothyroid	NN	B-NP	O
,	,	,	O	O
osteoporosis	osteoporosis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
hearing	hearing	NN	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Lantus	Lantus	NNP	B-NP	O
25	25	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
taper	taper	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
started	start	VBD	B-VP	O
11/29/06	11/29/06	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
half	half	JJ	I-NP	O
tab	tab	NN	I-NP	O
daily	daily	JJ	I-NP	O
x2	x2	NN	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
then	then	RB	O	O
half	half	NN	B-NP	O
tab	tab	NN	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
x2	x2	NN	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
2-3	2-3	CD	B-NP	I-protein
tabs	tab	NNS	I-NP	I-protein
p.o.	p.o.	FW	B-VP	O
daily	daily	RB	I-VP	O
depending	depend	VBG	I-VP	O
on	on	IN	B-PP	O
weight	weight	NN	B-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
12.5	12.5	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
Coumadin	Coumadin	NNP	I-NP	O
?	?	.	O	O

1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
nightly	nightly	RB	I-ADVP	O
,	,	,	O	O
fentanyl	fentanyl	NN	B-NP	O
25	25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
q.	q.	NN	I-NP	O
72h	72h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
potassium	potassium	NN	B-NP	O
,	,	,	O	O
levothyroxine	levothyroxine	NN	B-NP	O
75	75	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Penicillin	Penicillin	NNP	B-NP	O
causes	cause	VBZ	B-VP	O
red	red	JJ	B-NP	O
welts	welt	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
allergy	allergy	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
endorses	endors	NNS	I-NP	O
.	.	.	O	O

Cephalosporin	Cephalosporin	NN	B-NP	O
,	,	,	O	O
unknown	unknown	JJ	B-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O

Question	Question	NN	B-NP	O
for	for	IN	B-PP	O
quinolones	quinolone	NNS	B-NP	O
,	,	,	O	O
unknown	unknown	JJ	B-NP	O
reaction	reaction	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
without	without	IN	B-PP	O
a	a	DT	B-NP	O
problem	problem	NN	I-NP	O
.	.	.	O	O

Sulfa	Sulfa	NNP	B-NP	O
and	and	CC	I-NP	O
Bactrim	Bactrim	NNP	I-NP	O
,	,	,	O	O
unknown	unknown	JJ	B-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O

Codeine	Codeine	NN	B-NP	O
unknown	unknown	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
and	and	CC	O	O
five	five	CD	B-NP	O
grandchildren	grandchild	NNS	I-NP	O
,	,	,	O	O
ranging	range	VBG	B-VP	O
in	in	IN	B-PP	O
age	age	NN	B-NP	O
from	from	IN	B-PP	O
7	7	CD	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
20s	20s	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
former	former	JJ	I-NP	O
healthcare	healthcare	NN	I-NP	O
worker	worker	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
union	union	NN	I-NP	O
organizer	organizer	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
uses	use	VBZ	B-VP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
never	never	RB	B-ADVP	O
smoked	smoke	VBD	B-VP	O
tobacco	tobacco	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
very	very	RB	B-ADVP	O
rarely	rarely	RB	I-ADVP	O
drinks	drink	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
and	and	CC	O	O
never	never	RB	B-VP	O
used	use	VBD	I-VP	O
any	any	DT	B-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Parents	Parent	NNS	B-NP	O
:	:	:	O	O
Does	Do	VBZ	B-VP	O
not	not	RB	I-VP	O
know	know	VB	I-VP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
parents	parent	NNS	I-NP	O
or	or	CC	I-NP	O
siblings	sibling	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
son	son	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
98.7	98.7	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
98	98	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
171/85	171/85	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
19-23	19-23	CD	I-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
-98	-98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L	L	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	O
admission	admission	NN	I-NP	O
from	from	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
moaning	moan	VBG	I-VP	O
in	in	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
slightly	slightly	RB	B-ADJP	O
drowsy	drowsy	JJ	I-ADJP	O
,	,	,	O	O
but	but	CC	O	O
easily	easily	RB	B-ADJP	O
arouseable	arouseable	JJ	I-ADJP	O
.	.	.	O	O

Oriented	Orient	VBN	B-VP	O
to	to	TO	B-PP	O
person	person	NN	B-NP	O
,	,	,	O	O
''	''	''	O	O
Beebe	Beebe	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
''	''	''	O	O
,	,	,	O	O
and	and	CC	O	O
''	''	''	O	O
April	April	NNP	B-NP	O
''	''	''	O	O
.	.	.	O	O

Speaking	Speak	VBG	B-VP	O
in	in	IN	B-PP	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
.	.	.	O	O

ENT	ENT	NN	B-NP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
slightly	slightly	RB	B-NP	O
sluggishly	sluggishly	RB	I-NP	O
reactive	reactive	JJ	I-NP	O
pupils	pupil	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
oropharynx	oropharynx	NN	I-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
dry	dry	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
tachycardic	tachycardic	JJ	B-ADJP	O
,	,	,	O	O
regular	regular	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
distant	distant	JJ	I-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
normal	normal	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADJP	O
nontender	nontender	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
,	,	,	O	O
pain	pain	NN	B-NP	O
with	with	IN	B-PP	O
movement	movement	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
upper	upper	JJ	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
baseline	baseline	NN	B-NP	O
osteoarthritis	osteoarthritis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
shoulders	shoulder	NNS	I-NP	O
,	,	,	O	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-PP	O
left	left	JJ	B-ADJP	O
.	.	.	O	O

Right	Right	RB	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
had	have	VBD	B-VP	O
erythema	erythema	NN	B-NP	O
,	,	,	I-NP	O
warmth	warmth	NN	I-NP	O
and	and	CC	I-NP	O
2	2	CD	I-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
with	with	IN	B-PP	O
exquisite	exquisite	NN	B-NP	O
tenderness	tenderness	NN	I-NP	O
1	1	CD	I-NP	O
cm	cm	NN	I-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lateral	lateral	JJ	I-NP	O
distal	distal	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
had	have	VBD	B-VP	O
3	3	CD	B-NP	O
cm	cm	NN	I-NP	O
very	very	RB	B-NP	O
dark	dark	JJ	I-NP	O
black	black	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
near	near	IN	B-PP	O
the	the	DT	B-NP	O
biopsy	biopsy	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
cool	cool	JJ	B-ADJP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Left	Leave	VBN	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulse	pulse	NN	I-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
fourth	fourth	JJ	B-NP	O
and	and	CC	I-NP	O
fifth	fifth	JJ	I-NP	O
digit	digit	NN	I-NP	O
MCP-PIP	MCP-PIP	NN	I-NP	O
with	with	IN	B-PP	O
erythema	erythema	NN	B-NP	O
and	and	CC	I-NP	O
warmth	warmth	NN	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
,	,	,	I-NP	O
cranial	cranial	JJ	I-NP	O
nerves	nerve	NNS	I-NP	O
II	II	CD	B-NP	O
through	through	IN	B-PP	O
XII	XII	NN	B-NP	B-DNA
are	be	VBP	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

Moving	Move	VBG	B-VP	O
all	all	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

Full	Full	JJ	B-NP	O
strength	strength	NN	I-NP	O
exams	exam	NNS	I-NP	O
precluded	preclude	VBN	B-VP	O
by	by	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
V	V	NN	B-NP	O
pacing	pacing	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
on	on	IN	B-PP	O
8/7/06	8/7/06	CD	B-NP	O
showed	show	VBD	B-VP	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
IJ	IJ	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
consolidation	consolidation	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
overt	overt	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
or	or	CC	I-NP	O
pneumothorax	pneumothorax	NN	I-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
showed	show	VBD	B-VP	O
cellulitis	cellulitis	NN	B-NP	O
without	without	IN	B-PP	O
gas	gas	NN	B-NP	B-DNA
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
2004	2004	CD	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

RV	RV	NN	B-NP	O
was	be	VBD	B-VP	O
dilated	dilate	VBN	I-VP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
diastolic	diastolic	JJ	B-NP	O
septal	septal	JJ	I-NP	O
flattening	flattening	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
RV	RV	NN	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
by	by	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
mild-to-moderate	mild-to-moderate	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
PAP	PAP	NN	B-NP	B-protein
,	,	,	O	O
17	17	CD	B-NP	O
+	+	SYM	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
bicarbonate	bicarbonate	NN	B-NP	O
21	21	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
49	49	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	B-protein
1.6	1.6	CD	I-NP	I-protein
-LRB-	-LRB-	:	O	I-protein
baseline	baseline	NN	B-NP	I-protein
1.7	1.7	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
204	204	CD	B-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.3	1.3	CD	I-NP	O
,	,	,	O	O
lactic	lactic	JJ	B-NP	O
acid	acid	NN	I-NP	O
was	be	VBD	B-VP	O
6.5	6.5	CD	B-NP	O
going	go	VBG	B-VP	O
to	to	TO	B-PP	O
6.2	6.2	CD	B-NP	O
,	,	,	O	O
T	T	NN	B-NP	B-protein
bili	bili	NNS	I-NP	I-protein
was	be	VBD	B-VP	I-protein
1.5	1.5	CD	B-NP	I-protein
,	,	,	O	O
AST	AST	NN	B-NP	O
45	45	CD	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
1.4	1.4	CD	I-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	B-protein
43.2	43.2	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
156	156	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
9.8	9.8	CD	B-NP	O
with	with	IN	B-PP	O
84	84	CD	B-NP	O
%	%	NN	I-NP	O
neutrophils	neutrophil	NNS	I-NP	O
,	,	,	O	O
14	14	CD	B-NP	O
%	%	NN	I-NP	O
bands	band	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
lymph	lymph	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mono	mono	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
on	on	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
0.26	0.26	CD	B-NP	O
.	.	.	O	O

MICROBIOLOGY	MICROBIOLOGY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Blood	Blood	NN	B-NP	O
culture	culture	NN	I-NP	O
on	on	IN	B-PP	O
8/7/06	8/7/06	CD	B-NP	O
positive	positive	JJ	I-NP	O
for	for	IN	B-PP	O
beta	beta	NN	B-NP	O
hemolytic	hemolytic	JJ	I-NP	O
group	group	NN	I-NP	O
A	A	NN	I-NP	O
strep	strep	NN	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
on	on	IN	B-PP	O
8/7/06	8/7/06	CD	B-NP	O
,	,	,	O	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
klebsiella	klebsiella	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pansensitive	pansensitive	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
on	on	IN	B-PP	O
11/22/06	11/22/06	CD	B-NP	O
positive	positive	JJ	I-NP	O
for	for	IN	B-PP	O
beta	beta	NN	B-NP	O
hemolytic	hemolytic	JJ	I-NP	O
group	group	NN	I-NP	O
A	A	NN	I-NP	O
strep	strep	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
3/9/06	3/9/06	CD	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

Joint	Joint	NN	B-NP	O
fluid	fluid	NN	I-NP	O
on	on	IN	B-PP	O
6/7/06	6/7/06	CD	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
,	,	,	O	O
rare	rare	JJ	B-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
organisms	organism	NNS	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
Gram	Gram	NN	B-NP	B-protein
stain	stain	NN	I-NP	I-protein
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
from	from	IN	B-PP	O
1/4/06	1/4/06	CD	B-NP	O
,	,	,	I-NP	O
12	12	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
11/6/06	11/6/06	CD	B-NP	O
,	,	,	O	O
all	all	PDT	B-NP	O
no	no	DT	I-NP	O
growth	growth	NN	I-NP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

Stool	Stool	NN	B-NP	O
culture	culture	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
C.	C.	NNP	B-NP	O
diff	diff	NNP	I-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
fourth	fourth	JJ	I-NP	O
finger	finger	NN	I-NP	O
fluid	fluid	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
organisms	organism	NNS	B-NP	O
on	on	IN	B-PP	O
Gram	Gram	NN	B-NP	O
stain	stain	NN	I-NP	O
or	or	CC	I-NP	O
culture	culture	NN	I-NP	O
on	on	IN	B-PP	O
2/27/06	2/27/06	CD	B-NP	O
.	.	.	O	O

Sputum	Sputum	NN	B-NP	O
culture	culture	NN	I-NP	O
on	on	IN	B-PP	O
9/14/07	9/14/07	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	B-NP	O
suspected	suspect	VBN	B-VP	O
oral	oral	JJ	B-NP	O
flora	flora	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
on	on	IN	B-PP	O
9/14/07	9/14/07	CD	B-NP	O
,	,	,	O	O
hazy	hazy	JJ	B-NP	O
opacification	opacification	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
hemithorax	hemithorax	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
atelectasis	atelectasis	NN	B-NP	O
,	,	,	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
6/10/06	6/10/06	CD	B-NP	O
.	.	.	O	O

Right	Right	RB	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
fascial	fascial	JJ	I-NP	O
biopsy	biopsy	NN	I-NP	O
on	on	IN	B-PP	O
8/7/06	8/7/06	CD	B-NP	O
,	,	,	O	O
dense	dense	JJ	B-NP	O
fibroconnective	fibroconnective	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
inflammation	inflammation	NN	I-NP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Holoman	Holoman	NNP	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
83-year-old	83-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
sepsis	sepsis	NN	B-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
klebsiella	klebsiella	NN	I-NP	O
UTI	UTI	NN	I-NP	O
.	.	.	O	O

PLAN	PLAN	NN	B-NP	B-protein
:	:	:	O	I-protein
1	1	LS	B-LST	I-protein
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
group	group	NN	B-NP	O
A	A	NN	I-NP	O
strep	strep	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
cellulitis	cellulitis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
empirically	empirically	RB	B-ADVP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	B-protein
x6	x6	CD	B-NP	I-protein
weeks	week	NNS	I-NP	I-protein
.	.	.	O	O

Day	Day	NN	B-NP	O
one	one	CD	I-NP	O
was	be	VBD	B-VP	O
11/22/06	11/22/06	CD	B-NP	O
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
dosed	dose	VBN	I-VP	O
bilevel	bilevel	NN	B-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
requiring	require	VBG	I-VP	O
hemodialysis	hemodialysis	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
urine	urine	NN	B-NP	O
output	output	NN	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
vegetations	vegetation	NNS	B-NP	O
.	.	.	O	O

Second	Second	JJ	B-NP	O
echo	echo	NN	I-NP	O
was	be	VBD	B-VP	O
pending	pende	VBG	I-VP	O
on	on	IN	B-PP	O
10/27/07	10/27/07	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
any	any	DT	B-NP	O
kind	kind	NN	I-NP	O
of	of	IN	B-PP	O
vegetation	vegetation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
spots	spot	NNS	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
toes	toe	NNS	I-NP	O
that	that	WDT	B-NP	O
looked	look	VBD	B-VP	O
like	like	IN	B-PP	O
possible	possible	JJ	B-NP	O
Janeway	Janeway	NNP	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

Klebsiella	Klebsiella	NN	B-NP	O
UTI	UTI	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
oliguric	oliguric	JJ	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
with	with	IN	B-PP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
sepsis	sepsis	NN	B-NP	O
and	and	CC	I-NP	O
vasodilatation	vasodilatation	NN	I-NP	O
and	and	CC	I-NP	O
hypotension	hypotension	NN	I-NP	O
versus	versus	IN	B-PP	O
a	a	DT	B-NP	O
true	true	JJ	I-NP	O
ATN	ATN	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
requiring	require	VBG	I-VP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

Last	Last	JJ	B-NP	O
dialysis	dialysis	NN	I-NP	O
was	be	VBD	B-VP	O
10/27/07	10/27/07	CD	B-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
output	output	NN	I-NP	O
and	and	CC	I-NP	O
improving	improving	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
permanent	permanent	JJ	I-NP	O
tunneled	tunnel	VBN	I-NP	O
catheter	catheter	NN	I-NP	O
placed	place	VBD	B-VP	O
depending	depend	VBG	I-VP	O
on	on	IN	B-PP	O
how	how	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
recovers	recover	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
use	use	VB	I-VP	O
Lasix	Lasix	NNP	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
to	to	TO	B-VP	O
manage	manage	VB	I-VP	O
volume	volume	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
demand	demand	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
0.87	0.87	CD	B-NP	O
with	with	IN	B-PP	O
septic	septic	JJ	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
LDL	LDL	NN	I-NP	B-protein
was	be	VBD	B-VP	O
63	63	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
statin	statin	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
her	her	PRP$	B-NP	O
aspirin	aspirin	NN	I-NP	O
and	and	CC	I-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
recheck	recheck	VB	I-VP	O
her	her	PRP$	B-NP	O
fasting	fast	VBG	I-NP	O
lipids	lipid	NNS	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
illness	illness	NN	I-NP	O
has	have	VBZ	B-VP	O
resolved	resolve	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
now	now	RB	B-ADVP	O
has	have	VBZ	B-VP	O
normal	normal	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
with	with	IN	B-PP	O
titrating	titrate	VBG	B-VP	O
her	her	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
up	up	IN	B-PP	O
and	and	CC	O	O
considering	consider	VBG	B-VP	O
adding	add	VBG	I-VP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
agent	agent	NN	I-NP	O
to	to	TO	B-VP	O
normalize	normalize	VB	I-VP	O
her	her	PRP$	B-NP	O
hypotension	hypotension	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
are	be	VBP	B-VP	O
avoiding	avoid	VBG	I-VP	O
Ace	Ace	NNP	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
AFIB	AFIB	NN	B-NP	B-protein
,	,	,	O	O
sick	sick	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
permanent	permanent	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
are	be	VBP	B-VP	O
holding	hold	VBG	I-VP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
resumed	resume	VBN	I-VP	O
once	once	RB	B-NP	O
decision	decision	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
made	make	VBN	I-VP	O
about	about	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
access	access	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
INR	INR	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
,	,	,	O	O
presumably	presumably	RB	B-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
shock	shock	NN	B-NP	O
liver	liver	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
other	other	JJ	I-NP	O
LFTs	LFT	NNS	I-NP	B-protein
are	be	VBP	B-VP	O
also	also	RB	I-VP	O
increased	increase	VBN	I-VP	O
simultaneously	simultaneously	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
elevated	elevate	VBN	I-VP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
and	and	CC	I-NP	O
steroids	steroid	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
are	be	VBP	B-VP	O
titrating	titrate	VBG	I-VP	O
up	up	RP	B-PRT	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
is	be	VBZ	B-VP	O
Lantus	Lantus	NNP	B-NP	O
.	.	.	O	O

the	the	DT	B-NP	O
tube	tube	NN	I-NP	O
feeds	feed	NNS	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
10/27/07	10/27/07	CD	B-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
cleared	clear	VBN	I-VP	O
to	to	TO	I-VP	O
eat	eat	VB	I-VP	O
a	a	DT	B-NP	O
diabetic	diabetic	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
will	will	MD	B-VP	O
transition	transition	VB	I-VP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
accordingly	accordingly	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
hypothyroid	hypothyroid	JJ	B-ADJP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
Levoxyl	Levoxyl	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Rheumatology	Rheumatology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
gout	gout	NN	I-NP	O
flare	flare	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
shoulder	shoulder	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

Taps	Tap	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
gout	gout	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
taper	taper	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-VP	O
decreasing	decrease	VBG	I-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

on	on	IN	B-PP	O
7/9/07	7/9/07	CD	B-NP	O
per	per	IN	B-PP	O
rheumatology	rheumatology	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
persistently	persistently	RB	B-NP	B-cell_type
low	low	JJ	I-NP	I-cell_type
platelets	platelet	NNS	I-NP	I-cell_type
and	and	CC	I-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
DIC	DIC	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
fibrinogen	fibrinogen	NN	I-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
hemolysis	hemolysis	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
and	and	CC	I-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
dropped	drop	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
tapering	taper	VBG	B-VP	O
her	her	PRP$	B-NP	O
steroids	steroid	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
actually	actually	RB	B-ADVP	O
did	do	VBD	B-VP	O
require	require	VB	I-VP	O
two	two	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
on	on	IN	B-PP	O
2/27/06	2/27/06	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
increased	increase	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
platelet	platelet	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
IV	IV	CD	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
her	her	PRP$	B-NP	O
counts	count	NNS	I-NP	O
as	as	IN	B-SBAR	O
we	we	PRP	B-NP	O
taper	taper	VBP	B-VP	O
the	the	DT	B-NP	O
steroids	steroid	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
possible	possible	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
and	and	CC	I-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
are	be	VBP	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
sepsis	sepsis	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

GI	GI	NN	B-NP	O
on	on	IN	B-PP	O
8/27/06	8/27/06	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
elevated	elevate	VBN	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
the	the	DT	B-NP	O
trend	trend	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
and	and	CC	O	O
they	they	PRP	B-NP	O
have	have	VBP	B-VP	O
decreasing	decrease	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Neurology	Neurology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
severe	severe	JJ	B-NP	O
pain	pain	NN	I-NP	O
from	from	IN	B-PP	O
gout	gout	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Dilaudid	Dilaudid	NNP	I-NP	O
PCA	PCA	NN	I-NP	O
initially	initially	RB	B-ADVP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
fentanyl	fentanyl	NN	I-NP	O
patch	patch	NN	I-NP	O
with	with	IN	B-PP	O
Dilaudid	Dilaudid	JJ	B-NP	B-protein
boluses	bolus	NNS	I-NP	I-protein
p.r.n.	p.r.n.	NN	B-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Dermatology	Dermatology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
venostasis	venostasis	NN	B-NP	O
ulcers	ulcer	NNS	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
arterial	arterial	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
wound	wound	NN	B-NP	O
care	care	NN	I-NP	O
and	and	CC	O	O
vascular	vascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
their	their	PRP$	B-NP	O
recommendations	recommendation	NNS	I-NP	O
and	and	CC	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
ABIs	ABI	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
MRI	MRI	NN	I-NP	B-protein
to	to	TO	B-VP	O
study	study	VB	I-VP	O
flow	flow	NN	B-NP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
legs	leg	NNS	I-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
mechanical	mechanical	JJ	I-NP	O
soft	soft	JJ	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
thin	thin	JJ	B-NP	O
liquids	liquid	NNS	I-NP	O
on	on	IN	B-PP	O
10/27/07	10/27/07	CD	B-NP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
is	be	VBZ	B-VP	O
following	follow	VBG	I-VP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
when	when	WRB	B-ADVP	O
INR	INR	NN	B-NP	B-protein
hits	hit	VBZ	B-VP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
PPI	PPI	NN	I-NP	B-protein
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	B-cell_line
subclavian	subclavian	JJ	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
that	that	WDT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
removed	remove	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
decision	decision	NN	I-NP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
catheter	catheter	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
made	make	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
healthcare	healthcare	NN	I-NP	O
proxy	proxy	NN	I-NP	O
is	be	VBZ	B-VP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
,	,	,	O	O
Trotochaud	Trotochaud	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
cell	cell	NN	I-NP	O
number	number	NN	I-NP	O
739-718-1160	739-718-1160	CD	I-NP	O
,	,	,	O	O
home	home	NN	B-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
110-533-7410	110-533-7410	CD	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
:	:	:	O	O
DNR/DNI	DNR/DNI	NN	B-NP	O
.	.	.	O	O

CONTINUED	CONTINUED	VBN	B-NP	O
CARE	CARE	NN	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
cultures	culture	NNS	I-NP	O
to	to	TO	B-PP	O
resolution	resolution	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Remove	Remove	VB	B-VP	O
right	right	JJ	B-NP	O
subclavian	subclavian	JJ	I-NP	O
line	line	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Make	Make	VB	B-VP	O
a	a	DT	B-NP	O
decision	decision	NN	I-NP	O
about	about	IN	B-PP	O
whether	whether	IN	B-SBAR	O
or	or	CC	O	O
not	not	RB	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
intermittent	intermittent	JJ	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
and	and	CC	O	O
if	if	IN	B-SBAR	O
so	so	RB	B-ADVP	O
,	,	,	O	O
through	through	IN	B-PP	O
what	what	WP	B-NP	O
access	access	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Resume	Resume	NNP	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
once	once	RB	B-ADVP	O
that	that	IN	B-SBAR	O
access	access	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
placed	place	VBN	I-VP	O
or	or	CC	O	O
once	once	RB	O	O
all	all	DT	B-NP	O
lines	line	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
removed	remove	VBN	I-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Recheck	Recheck	NN	B-NP	O
lipids	lipid	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

ABIs	ABI	NNS	B-NP	O
for	for	IN	B-PP	O
both	both	DT	B-NP	O
legs	leg	NNS	I-NP	O
and	and	CC	I-NP	O
followup	followup	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
,	,	,	I-NP	O
non-healing	non-healing	JJ	I-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-0424668	5-0424668	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
COTTRELL	COTTRELL	NN	B-NP	O
,	,	,	O	O
TERRELL	TERRELL	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SPRAKER	SPRAKER	NN	B-NP	O
,	,	,	O	O
CODY	CODY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6205116	6205116	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/27/07	10/27/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/9/07	7/9/07	CD	B-NP	O

